GentiBio
Adan is the Senior Director of Quality at GentiBio. Adan has over 20 years of experience in the biotechnology and pharmaceutical industry including the cell therapy companies Juno Therapeutics, Sonoma Biotherapeutics, and Dendreon. In his most recent roles, Adan has been responsible for building out the Quality infrastructure, systems, and business processes to enable product manufacturing in support of clinical trials and commercialization. Adan’s experience includes leading Quality groups accountable for vendor management, audit program, apheresis site onboarding, Clinical QA, and production site QA operations. Adan’s work has supported the clinical development and commercialization of three cellular therapies (Breyanzi, Abecma, and Provenge). Adan received his B.A. from the University of Southern California (Fight On!).
This person is not in any offices
GentiBio
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.